Displaying 1 - 5 of 5
| Active Ingredient | ESOMEPRAZOLE |
| Therapeutic Class | PROTON PUMP INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | LANSOPRAZOLE |
| Therapeutic Class | PROTON PUMP INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | OMEPRAZOLE |
| Therapeutic Class | PROTON PUMP INHIBITORS |
| Indications | Duodenal and gastric ulcers. Gastroesophageal reflux disease. |
| Caution |
Constipation, diarrhea, headache, nausea, rash. Capsule is to be swallowed whole. c.f. prescribing in liver disease p. 16. |
| Dose Range | Peptic ulcer: 20 - 40 mg daily depending on severity ; 4 weeks for duodenal ulcer and 8 weeks for gastric ulcer; maintenance: 20 mg once daily .GERD: 20mg once daily for 4 weeks, followed by a further 4 - 8 weeks if not fully healed. Take before break |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PANTOPRAZOLE |
| Therapeutic Class | PROTON PUMP INHIBITORS |
| Indications | Short term treatment of GERD (7-10 day s). |
| Caution | Diarrhea, nausea, headache. Safety and efficacy not established in children. |
| Dose Range | i.v: 40mg once daily for 7-10 day . See protocol pg. xiii section 7 and 8. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | RABEPRAZOLE |
| Therapeutic Class | PROTON PUMP INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |